Trial Profile
A retrospective study to compare the clinical efficacy of abiraterone acetate with ketoconazole in chemotherapy-naive patients with metastatic castration resistant prostate cancer (mCRPC)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Apr 2016
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary) ; Ketoconazole
- Indications Prostate cancer
- Focus Therapeutic Use
- 05 Apr 2016 New trial record